These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 27386821)
1. The Glycated Albumin (GA) to HbA1c Ratio Reflects Shorter-Term Glycemic Control than GA: Analysis of Patients with Fulminant Type 1 Diabetes. Koga M; Inada S; Nakao T; Kawamori R; Kasayama S J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27386821 [TBL] [Abstract][Full Text] [Related]
2. Glycemic control indicator levels at diagnosis of neonatal diabetes mellitus: Comparison with other types of insulin-dependent diabetes mellitus. Suzuki S; Furuya A; Tanahashi Y; Azuma H; Bando Y; Kasayama S; Koga M Pediatr Diabetes; 2017 Dec; 18(8):767-771. PubMed ID: 27995726 [TBL] [Abstract][Full Text] [Related]
3. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus. Koga M; Murai J; Morita S; Saito H; Kasayama S J Diabetes Complications; 2013; 27(3):211-3. PubMed ID: 23312788 [TBL] [Abstract][Full Text] [Related]
4. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review. Yazdanpanah S; Rabiee M; Tahriri M; Abdolrahim M; Rajab A; Jazayeri HE; Tayebi L Crit Rev Clin Lab Sci; 2017 Jun; 54(4):219-232. PubMed ID: 28393586 [TBL] [Abstract][Full Text] [Related]
6. Calculation of HbA1c and glycated albumin from serially measured self-monitored blood glucose in patients with type 1 diabetes mellitus. Koga M; Suzuki S; Matsuo K; Tanahashi Y; Azuma H; Kasayama S Clin Chim Acta; 2013 Oct; 425():188-91. PubMed ID: 23933122 [TBL] [Abstract][Full Text] [Related]
7. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)]. Sato A Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426 [TBL] [Abstract][Full Text] [Related]
8. Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes. Matsumoto H; Murase-Mishiba Y; Yamamoto N; Sugitatsu-Nakatsukasa S; Shibasaki S; Sano H; Terasaki J; Imagawa A; Hanafusa T Intern Med; 2012; 51(11):1315-21. PubMed ID: 22687835 [TBL] [Abstract][Full Text] [Related]
9. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis. Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356 [TBL] [Abstract][Full Text] [Related]
10. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis. Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597 [TBL] [Abstract][Full Text] [Related]
11. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Takahashi S; Uchino H; Shimizu T; Kanazawa A; Tamura Y; Sakai K; Watada H; Hirose T; Kawamori R; Tanaka Y Endocr J; 2007 Feb; 54(1):139-44. PubMed ID: 17159300 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring. Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415 [TBL] [Abstract][Full Text] [Related]
13. Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study. Lu JM; Ji LN; Li YF; Li QM; Lin SS; Lv XF; Wang L; Xu Y; Guo XH; Guo QY; Ma L; Du J; Chen YL; Zhao CL; Zhang QL; She QM; Jiao XM; Lu MH; Pan RQ; Gao Y J Diabetes Complications; 2016; 30(8):1609-1613. PubMed ID: 27496253 [TBL] [Abstract][Full Text] [Related]
14. Glycated albumin in diabetic patients with chronic kidney disease. Zheng CM; Ma WY; Wu CC; Lu KC Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of glycated albumin for early detection of deterioration of glycemic control state after discharge from educational admission. Murai J; Soga S; Saito H; Koga M Endocr J; 2013; 60(4):409-13. PubMed ID: 23221004 [TBL] [Abstract][Full Text] [Related]
17. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530 [TBL] [Abstract][Full Text] [Related]
18. Is glycated albumin useful for differential diagnosis between fulminant type 1 diabetes mellitus and acute-onset autoimmune type 1 diabetes mellitus? Koga M; Kanehara H; Bando Y; Morita S; Kasayama S Clin Chim Acta; 2015 Dec; 451(Pt B):297-300. PubMed ID: 26477482 [TBL] [Abstract][Full Text] [Related]
19. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges. Gan T; Liao B; Xu G J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445 [TBL] [Abstract][Full Text] [Related]
20. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis. Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]